This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | Origin |
|---|---|---|---|---|
| DRACP03809 | Mitoparan [L14T], Mastoparan [A5,8K;A10Aib;L14T] | INLKKLAKLXKKIT | 14 | Synthetic |
| DRACP03810 | Arenicin-3 [G1,12A; Y5N; Y17H], N2 | AFCWNVCVYRNAVRVCHRRCN | 21 | Synthetic |
| DRACP03811 | MK58911 | INWLKIAKKVKGML | 14 | Synthetic |
| DRACP03813 | Mycobacterium phage peptide (33-47)[G12W, A13W], AK15 | AKKKLSRWWLRWWVK | 15 | Synthetic |
| DRACP03814 | Mycobacterium phage peptide (33-47)[K2V, S6L, L10S, G12W, A13W, W14K], AK15-6 | AVKKLLRWWSRWWKK | 15 | Synthetic |
| DRACP03815 | WVKAAAKAAAKVW | 13 | Synthetic | |
| DRACP03816 | WIKAAAKAAAKIW | 13 | Synthetic | |
| DRACP03817 | WFKAAAKAAAKFW | 13 | Synthetic | |
| DRACP03818 | WWKAAAKAAAKWW | 13 | Synthetic | |
| DRACP03820 | Cecropin-B [E27Q] | RWKIFKKIEKMGRNIRDGIVKAGPAIQVLGSAKAI | 35 | Synthetic |
| DRACP03822 | NN2_0018 | YLARAIRRTLARLLL | 15 | Synthetic |
| DRACP03823 | NN2_0050 | SWKKFFKKARSLPKLF | 16 | Synthetic |
| DRACP03826 | D4E1 | FKLRAKIKVRLRAKIKL | 17 | Synthetic |
| DRACP03827 | LALALALALALALALALALALA | 22 | Synthetic | |
| DRACP03828 | FhHDM-1p2 | AMAYLAKDNLGEKITEVITILLNRLTDRLEKYAG | 34 | Synthetic |
| DRACP03829 | SPO-1 protein (73-107), Sm16-p73 | MDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKK | 35 | Synthetic |
| DRACP03830 | SmHDM-1p146 | IDTYSRKDDLDKKLLEVAKIIGRRLEKRHEYLAMK | 35 | Synthetic |
| DRACP03831 | SmHDM-2p58, Smp_194860 (54-85) | IRKYLEEDNLGEKLAAVVSIYVKRLNKRLDMR | 32 | Synthetic |
| DRACP03832 | FhHDM-1p2 (14-31) | ITEVITILLNRLTDRLEK | 18 | Synthetic |
| DRACP03833 | FhHDM-1p2 (14-31) [E3K, I7K, D14K, R15K, E17S] | ITKVITKLLNRLTKILSK | 18 | Synthetic |
| DRACP03836 | C18-GG-BP100 | GGKKLFKKILKYL | 13 | Synthetic |
| DRACP03837 | Arenicin-1 [V4R; Y5,7R; A6Y; R16,18Y; Y17A; R19V] | RWCRRYRVRVRGVLVYAYVCW | 21 | Synthetic |
| DRACP03838 | R-Arenicin-1 [L15R; R17,19Y; Y18A; R20V] | RRWCVYAYVRVRGVRVYAYVCW | 22 | Synthetic |
| DRACP03839 | Arenicin (2-21) [V3R; Y4,6R; A5Y; R8L] | WCRRYRVLVRGVLVRYRRCW | 20 | Synthetic |
| DRACP03840 | Arenicin-1 (1-10)-Orn-Dap + Arenicin-1 (1-10) | RWCVYAYVRVXX,RWCVYAYVRV | 23 | Synthetic |
| DRACP03841 | Invert Arenicin-1 (13-21)-Orn-Dap + Invert Arenicin-1 (13-21) | WCRRYRVLVXX,WCRRYRVLV | 21 | Synthetic |
| DRACP03842 | Arenicin-1 [W2,21F] | RFCVYAYVRVRGVLVRYRRCF | 21 | Synthetic |
| DRACP03843 | Linear Arenicin-1 [C3,20IAA-Cys] | RWXVYAYVRVRGVLVRYRRXW | 21 | Synthetic |
| DRACP03844 | Oncocin [D2R,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn] | VRKPPYLPRPRWXRXXYNX | 19 | Synthetic |
| DRACP03845 | Oncocin [D2Orn,P12W,P13Hyp,R15Hyp,I16Tle,R19Orn] | VXKPPYLPRPRWXRXXYNX | 19 | Synthetic |
This work is licensed under a Creative Commons Attribution 4.0 International License.